Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives.

Guillon J, Cohen A, Boudot C, Valle A, Milano V, Das RN, Guédin A, Moreau S, Ronga L, Savrimoutou S, Demourgues M, Reviriego E, Rubio S, Ferriez S, Agnamey P, Pauc C, Moukha S, Dozolme P, Nascimento SD, Laumaillé P, Bouchut A, Azas N, Mergny JL, Mullié C, Sonnet P, Courtioux B.

J Enzyme Inhib Med Chem. 2020 Dec;35(1):432-459. doi: 10.1080/14756366.2019.1706502.

2.

Design, Synthesis and Biological Evaluation of New Substituted Diquinolinyl-Pyridine Ligands as Anticancer Agents by Targeting G-Quadruplex.

Das RN, Chevret E, Desplat V, Rubio S, Mergny JL, Guillon J.

Molecules. 2017 Dec 30;23(1). pii: E81. doi: 10.3390/molecules23010081.

3.

Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives.

Guillon J, Cohen A, Das RN, Boudot C, Gueddouda NM, Moreau S, Ronga L, Savrimoutou S, Basmaciyan L, Tisnerat C, Mestanier S, Rubio S, Amaziane S, Dassonville-Klimpt A, Azas N, Courtioux B, Mergny JL, Mullié C, Sonnet P.

Chem Biol Drug Des. 2018 May;91(5):974-995. doi: 10.1111/cbdd.13164. Epub 2018 Jan 17.

PMID:
29266861
4.

Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells.

Desplat V, Vincenzi M, Lucas R, Moreau S, Savrimoutou S, Rubio S, Pinaud N, Bigat D, Enriquez E, Marchivie M, Routier S, Sonnet P, Rossi F, Ronga L, Guillon J.

ChemMedChem. 2017 Jun 21;12(12):940-953. doi: 10.1002/cmdc.201700049. Epub 2017 Apr 5.

PMID:
28218826
5.

Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives.

Guillon J, Cohen A, Gueddouda NM, Das RN, Moreau S, Ronga L, Savrimoutou S, Basmaciyan L, Monnier A, Monget M, Rubio S, Garnerin T, Azas N, Mergny JL, Mullié C, Sonnet P.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):547-563. doi: 10.1080/14756366.2016.1268608.

6.

Design, Synthesis, and Evaluation of 2,9-Bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline Derivatives as G-Quadruplex Ligands.

Gueddouda NM, Hurtado MR, Moreau S, Ronga L, Das RN, Savrimoutou S, Rubio S, Marchand A, Mendoza O, Marchivie M, Elmi L, Chansavang A, Desplat V, Gabelica V, Bourdoncle A, Mergny JL, Guillon J.

ChemMedChem. 2017 Jan 20;12(2):146-160. doi: 10.1002/cmdc.201600511. Epub 2017 Jan 3.

7.

Diminished oligomerization in the synthesis of new anti-angiogenic cyclic peptide using solution instead of solid-phase cyclization.

Rubio S, Clarhaut J, Péraudeau E, Vincenzi M, Soum C, Rossi F, Guillon J, Papot S, Ronga L.

Biopolymers. 2016 May;106(3):368-75. doi: 10.1002/bip.22814.

PMID:
26832831
8.

Discrimination and categorization of emotional facial expressions and faces in Parkinson's disease.

Alonso-Recio L, Martín P, Rubio S, Serrano JM.

J Neuropsychol. 2014 Sep;8(2):269-88. doi: 10.1111/jnp.12029. Epub 2013 Aug 31.

PMID:
23992026
9.

Is a neutral expression also a neutral stimulus? A study with functional magnetic resonance.

Carvajal F, Rubio S, Serrano JM, Ríos-Lago M, Alvarez-Linera J, Pacheco L, Martín P.

Exp Brain Res. 2013 Aug;228(4):467-79. doi: 10.1007/s00221-013-3578-1. Epub 2013 Jun 2.

10.

Design, characterization, and evaluation of peptide arrays allowing the direct monitoring of MMP activities.

Alouini MA, Moustoifa el-F, Rubio SA, Bartegi A, Berthelot T, Déléris G.

Anal Bioanal Chem. 2012 Apr;403(1):185-94. doi: 10.1007/s00216-012-5760-x. Epub 2012 Feb 23.

PMID:
22354570
11.

Differential regional brain responses to induced maternal behavior in rats measured by cytochrome oxidase immunohistochemistry.

Pérez-Laso C, Rubio S, Martín JL, Gómez F, Segovia S, Del Cerro MC.

Behav Brain Res. 2011 Oct 1;223(2):293-6. doi: 10.1016/j.bbr.2011.04.046. Epub 2011 May 5.

PMID:
21569801
12.

Gut-brain chemokine changes in portal hypertensive rats.

Merino J, Aller MA, Rubio S, Arias N, Nava MP, Loscertales M, Arias J, Arias JL.

Dig Dis Sci. 2011 Aug;56(8):2309-17. doi: 10.1007/s10620-011-1625-y. Epub 2011 Feb 24.

PMID:
21347560
13.

Portal hypertension in 18-month-old rats: memory deficits and brain metabolic activity.

Begega A, Méndez M, Rubio S, Santín LJ, Aller MA, Arias J, Arias JL.

Physiol Behav. 2010 May 11;100(2):135-42. doi: 10.1016/j.physbeh.2010.02.014. Epub 2010 Feb 23.

PMID:
20184905
14.

Perception and recall of faces and facial expressions following temporal lobectomy.

Carvajal F, Rubio S, Martín P, Serrano JM, García-Sola R.

Epilepsy Behav. 2009 Jan;14(1):60-5. doi: 10.1016/j.yebeh.2008.08.016. Epub 2008 Oct 2.

PMID:
18804183
15.

The role of the amygdala in facial emotional expression during a discrimination task.

Carvajal F, Rubio S, Martín P, Amarante C, García-Sola R.

Psicothema. 2007 Feb;19(1):23-9.

PMID:
17295979
16.

Hippocampal and caudate metabolic activity associated with different navigational strategies.

Miranda R, Blanco E, Begega A, Rubio S, Arias JL.

Behav Neurosci. 2006 Jun;120(3):641-50.

PMID:
16768616

Supplemental Content

Loading ...
Support Center